Searched for
ARCH PHARMA LABS
India imposes anti-dumping duty on ursodiolAn industry expert said China had been “unfairly dumping” the chemical, which had brought down its local price from $350 a kg in 2018 to $1...- India initiates anti-dumping probe against Chinese pharma chemicalIf it is established that the dumping has caused material injury to the domestic players, the DGTR would recommend the imposition of anti-d...
- DeliveranceE-commerce companies will only be allowed to deliver essential goods in Maharashtra from tomorrow. We’re getting that 2020 feeling again.
- Trip and fallThe Covid pandemic has been disastrous for the travel sector in general and 15-year-old Cleartrip in particular. A year after it laid off a...
- Banks sell portion of Arch pharma’s Rs 3,000-crore loan at half the valueThe Corporate Debt Restructuring Proposal was referred to the CDR cell in May 2013 after Arch Pharma Labs was struggling under a debt burde...
- Top drug makers like Sun Pharma, Torrent, Cipla working on quality standards at manufacturing facilitiesArch rivals are grouping to look for a lasting solution to what external subject experts call “deeply ingrained culture issue”.
- Bulk drugs from China floods Indian market, leaves indigenous products in dire straitsThe Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support th...
- Sensex rangebound; sixteen stocks in actionAccording to analysts, Q4 earnings and global economic situation are likely to decide the course of markets in the near term.
- United Bank of India labels Bilcare as 'wilful defaulter' in a 'war on NPAs', to send winding-up noticeUnited Bank of India has taken action against four loan defaulters in an attempt to reduce its non-performing loans.
- Fifteen stocks in focus in Tuesday morning tradeIndian shares are expected to trade in a range. Here is a list of fifteen stocks that are likely to be in action in morning trade today.
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Is Indian pharmaceutical industry losing its sheen? Promoters exit for attractive alternativesThe question is whether the business per se is attractive for everyone, says Hitesh Sharma, partner and national leader at Ernst & Young.
- ICICI Venture to exit I-Ven PharmaICICI Venture, India's largest private equity player, is set to divest its entire stake in I-Ven Pharma Capital, a special purpose vehicle,...
- Mid-cap pharma firms focus on LatAm marketLupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
- Orchid may use warrants as defenceAs a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...
- Ranbaxy picks up 9.54% stake in Orchid ChemicalsA creeping acquisition has begun in the shares of Chennai-based Orchid Chemicals & Pharmaceuticals which has become vulnerable to acquisiti...
- Strategic movesFor companies big and small CRM has become a necessity - SMEs in particular have realised its vast importance.
Load More
